celiprolol has been researched along with Myocardial Ischemia in 5 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celiprolol is a selective beta(1)-adrenoceptor antagonist with antihypertensive actions, which causes renal vasodilation by increasing tissue nitric oxide (NO) levels." | 5.32 | Celiprolol increases coronary blood flow and reduces severity of myocardial ischemia via nitric oxide release. ( Asakura, M; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Minamino, T; Node, K; Ogita, H; Sakata, Y; Sanada, S; Tada, M; Takashima, S; Ueda, Y, 2003) |
| "Celiprolol is a selective beta(1)-adrenoceptor antagonist with antihypertensive actions, which causes renal vasodilation by increasing tissue nitric oxide (NO) levels." | 1.32 | Celiprolol increases coronary blood flow and reduces severity of myocardial ischemia via nitric oxide release. ( Asakura, M; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Minamino, T; Node, K; Ogita, H; Sakata, Y; Sanada, S; Tada, M; Takashima, S; Ueda, Y, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, H | 1 |
| Node, K | 1 |
| Minamino, T | 1 |
| Sanada, S | 1 |
| Takashima, S | 1 |
| Ueda, Y | 1 |
| Sakata, Y | 1 |
| Asakura, M | 1 |
| Kim, J | 1 |
| Ogita, H | 1 |
| Tada, M | 1 |
| Hori, M | 1 |
| Kitakaze, M | 1 |
| Fejfar, Z | 1 |
| Vrána, M | 1 |
| Schweizer, J | 1 |
| Kaulen, R | 1 |
| Nierade, A | 1 |
| Altmann, E | 1 |
| Owens, P | 1 |
| O'Brien, E | 1 |
| Iagenskiĭ, AV | 1 |
| Barsukov, BP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "PGDT With the Hypotension Prediction Index to Reduce the Number and Duration of Intraoperative Hypotension and the Incidence of Renal Failure in Patients Undergoing Lung Surgery"[NCT04149314] | 142 participants (Actual) | Interventional | 2019-11-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for celiprolol and Myocardial Ischemia
| Article | Year |
|---|---|
[The third generation of b-blockers: new possibilities ].
Topics: Adrenergic beta-Antagonists; Asthma; Celiprolol; Hemodynamics; Humans; Hypertension; Lipoproteins, H | 1992 |
1 trial available for celiprolol and Myocardial Ischemia
| Article | Year |
|---|---|
Beta-blockers and nitrates in patients with peripheral arterial occlusive disease: long-term findings.
Topics: Adrenergic beta-Antagonists; Aged; Arterial Occlusive Diseases; Atenolol; Blood Flow Velocity; Celip | 1997 |
3 other studies available for celiprolol and Myocardial Ischemia
| Article | Year |
|---|---|
Celiprolol increases coronary blood flow and reduces severity of myocardial ischemia via nitric oxide release.
Topics: Animals; Celiprolol; Coronary Circulation; Dogs; Enzyme Inhibitors; Myocardial Ischemia; Nitric Oxid | 2003 |
Dogs at high or low risk of ventricular fibrillation. An experimental study of acute myocardial ischaemia.
Topics: Acute Disease; Animals; Cardiac Pacing, Artificial; Celiprolol; Dogs; Flunitrazepam; Heart Rate; Mal | 1993 |
Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Amb | 1999 |